Skip to the page

Data / Form D filings / Star Therapeutics LLC

Star Therapeutics LLC: Form D filing

Star Therapeutics LLC, a company in South San Francisco, CA, filed a Form D with the SEC in 2025. The latest, on October 6, 2025, reports $125 million sold of a $125 million offering to 21 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
201 HASKINS WAY, 5TH FLOOR, South San Francisco, CA, 94080
Phone
(888) 742-1338
Industry
Other
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2088123

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 6, 2025New notice$124,999,974$124,999,97421Sep 22, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jason HaflerDirector
Nancy StaglianoDirector
Michelle CarpenterExecutive Officer
Carl GordonDirector
Matthew FustDirector
Amrit NagpalDirector
Beth SeidenbergDirector
Sandip PanickerExecutive Officer
Scott RobertsonExecutive Officer
Adam RosenthalExecutive Officer, Director
Maha KatabiDirector
Gary PatouExecutive Officer

Other companies in California that filed recently

Every Form D from the week of Oct 6, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Star Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.